Stocks
Recursion Projects 2028 Runway, Holds 2026 Expenses Below $390M
Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...
Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...
Twilio (TWLO) has significantly raised its 2026 financial projections, now forecasting organic growth between 9.5% and 10.5% and non-GAAP operating income of...
FRP Holdings, Inc. (FRPH) has projected a Net Operating Income (NOI) between $37.1 million and $37.7 million for 2026, aligning with its...